PIP5KL1 Antibody

What is PIP5KL1 and what cellular functions does it involve?

PIP5KL1 (Phosphatidylinositol-4-Phosphate 5-Kinase-Like 1) is a phosphoinositide kinase-like protein that lacks intrinsic lipid kinase activity but associates with type I PIPKs. It primarily functions as a scaffold to localize and regulate type I PI4P 5-kinases to specific cellular compartments where they generate PI(4,5)P2 for actin nucleation, signaling, scaffold protein recruitment, and conversion to PI(3,4,5)P3 . The protein is encoded by the PIP5KL1 gene (Gene ID: 138429) in humans and has a calculated molecular weight of approximately 44.6 kDa .

What applications are PIP5KL1 antibodies commonly validated for?

PIP5KL1 antibodies have been validated for multiple experimental applications, with specific optimal dilutions:

What species reactivity is confirmed for PIP5KL1 antibodies?

Most commercial PIP5KL1 antibodies have been validated for human reactivity, with some demonstrating cross-reactivity with other species:

BLAST analysis indicates sequence conservation across primates (100% for Human, Chimpanzee, Gorilla, Gibbon, and Monkey) with good homology to other mammals .

What are the common immunogens used for PIP5KL1 antibody production?

PIP5KL1 antibodies are typically generated using several immunogen strategies:

• KLH-conjugated synthetic peptides from the N-terminal region (amino acids 57-86)

• Synthetic peptides located between aa74-123 of human PIP5KL1

• PIP5KL1 fusion proteins

• Recombinant protein fragments covering specific domains

The epitope selection significantly impacts antibody specificity and application performance.

How can I properly validate the specificity of a PIP5KL1 antibody?

A comprehensive validation approach should include:

• Western blot with positive controls: Use cell lines known to express PIP5KL1 (HEK-293 cells, human brain tissue)

• Molecular weight verification: Confirm band at the expected ~45 kDa (observed molecular weight)

• Knockdown/knockout controls: Compare antibody reactivity in wildtype versus PIP5KL1-depleted samples

• Peptide competition assay: Pre-incubate antibody with immunizing peptide to confirm signal specificity

• Orthogonal validation: Compare results with a second antibody targeting a different PIP5KL1 epitope

• Cross-reactivity assessment: Especially important when studying multiple PIP5K family members

• Immunofluorescence localization pattern: Compare with literature-reported subcellular distribution

What are the key differences between PIP5KL1 and related PIP5K family members?

Understanding these differences is crucial for experimental design and data interpretation:

PIP5KL1 is unique among family members in its lack of catalytic activity, functioning instead as a regulatory scaffold protein.

How should I optimize PIP5KL1 antibody protocols for Western blotting?

For optimal Western blot results with PIP5KL1 antibodies:

• Sample preparation:

  • Include phosphatase inhibitors to preserve physiological phosphorylation states

  • Use freshly prepared lysates when possible

  • Load 20-35μg protein per lane (based on validated protocols)

• Antibody dilution optimization:

  • Start with manufacturer's recommended dilution (typically 1:500-1:1000)

  • Create a dilution series (e.g., 1:250, 1:500, 1:1000, 1:2000) to find optimal signal-to-noise ratio

  • Primary antibody incubation: overnight at 4°C for best results

• Blocking optimization:

  • Test different blocking agents (5% non-fat dry milk vs. 5% BSA)

  • Blocking time: 1 hour at room temperature or overnight at 4°C

• Detection system considerations:

  • For low abundance targets, consider enhanced chemiluminescence or fluorescent secondary antibodies

  • Secondary antibody dilution: typically 1:5000

What are the best practices for immunofluorescence experiments using PIP5KL1 antibodies?

For optimal immunofluorescence detection of PIP5KL1:

• Fixation and permeabilization:

  • 4% paraformaldehyde (10-15 minutes) followed by 0.1-0.25% Triton X-100 permeabilization

  • Alternative: methanol fixation (-20°C for 10 minutes) for certain epitopes

• Antibody application:

  • Dilution range: 1:10-1:50 (optimal based on validation data)

  • Incubation: overnight at 4°C for maximum sensitivity

  • Include negative controls (secondary antibody only, non-immune IgG)

• Imaging parameters:

  • Confocal microscopy recommended for subcellular localization studies

  • Use DAPI nuclear counterstain as reference point

  • Consider co-staining with markers of relevant subcellular compartments

• Signal validation:

  • Compare pattern with published subcellular localization data

  • Perform siRNA knockdown controls to confirm specificity

How do PIP5K1A and PIP5K1C silencing affect cellular processes compared to PIP5KL1?

Research has revealed distinct roles for different PIP5K family members:

• PIP5K1A silencing:

  • Decreases total cellular PI(4,5)P2 levels significantly

  • Reduces Pr55 Gag accumulation at plasma membrane in HIV-1 studies

  • Leads to protein degradation through lysosome and proteasome pathways

  • Affects HIV-1 entry and early steps of infection

• PIP5K1C silencing:

  • Prevents ACE2-mediated endocytosis relevant to SARS-CoV-2 infection

  • Leads to Pr55 Gag accumulation in late endosomes rather than degradation

  • Demonstrated embryonic lethality in knockout mouse models

• PIP5KL1 effects (less well characterized):

  • May act as scaffold protein rather than directly affecting PI(4,5)P2 levels

  • Likely regulates the localization of active PIP5K family members

How can I design effective knockdown/knockout controls for PIP5KL1 antibody validation?

For rigorous validation through genetic manipulation:

• siRNA approach:

  • Design 2-3 different siRNA sequences targeting different PIP5KL1 regions

  • Include non-targeting control siRNA

  • Validate knockdown by qRT-PCR (aim for >70% reduction)

  • Confirm protein reduction by Western blot with the antibody being validated

• CRISPR/Cas9 knockout strategy:

  • Design guide RNAs targeting early exons

  • Generate and sequence-verify clonal knockout lines

  • Include heterozygous knockouts as intermediate controls

  • Monitor potential compensatory upregulation of other family members

• Validation controls:

  • Use positive control cell lines (e.g., HEK-293, which shows detectable expression)

  • Perform parallel experiments with commercial positive control lysates

  • Consider rescue experiments with exogenous PIP5KL1 expression

What approaches can detect protein-protein interactions involving PIP5KL1?

To investigate PIP5KL1's scaffolding functions:

• Co-immunoprecipitation strategies:

  • Use anti-PIP5KL1 antibodies for pulldown (if epitope is accessible in native conditions)

  • Alternative: epitope-tagged PIP5KL1 expression and tag-based purification

  • Western blot for suspected interaction partners (particularly other PIP5K family members)

• Proximity labeling approaches:

  • BioID or TurboID fusion with PIP5KL1 to identify proximal proteins

  • APEX2 labeling to capture transient interactions

• Fluorescence-based interaction methods:

  • FRET/BRET to study direct interactions in living cells

  • Fluorescence colocalization with other phosphoinositide metabolism proteins

• Mass spectrometry-based approaches:

  • Immunoprecipitation followed by MS to identify interaction partners

  • Crosslinking MS to capture structural details of PIP5KL1 complexes

How can I integrate PIP5KL1 antibody research with functional phosphoinositide metabolism studies?

For comprehensive analysis:

• Combined antibody and lipid analysis approaches:

  • Correlate PIP5KL1 protein levels (by Western blot) with PI(4,5)P2 levels

  • Use Ultra-high-pressure liquid chromatography coupled with high-resolution mass spectrometry (UHPLC-HRMS-MS) for phosphoinositide analysis

  • Monitor cellular phenotypes in parallel with both protein and lipid measurements

• PIP5KL1 localization and PI(4,5)P2 visualization:

  • Use PIP5KL1 antibodies for immunofluorescence alongside PI(4,5)P2 biosensors

  • Analyze colocalization patterns in different subcellular compartments

  • Apply super-resolution microscopy for detailed spatial relationships

• Experimental design considerations:

  • Include appropriate inhibitors of phosphoinositide metabolism

  • Design time-course experiments to capture dynamic changes

  • Consider subcellular fractionation to analyze compartment-specific changes

What are current knowledge gaps in PIP5KL1 research?

Despite available antibody tools, several aspects of PIP5KL1 biology remain poorly understood:

• Precise scaffolding mechanisms: How PIP5KL1 regulates other PIP5K family members

• Tissue-specific functions: Variations in expression and function across cell types

• Disease associations: Unlike PIP5K1A (breast cancer) and PIP5K1C (viral infections), PIP5KL1's role in pathologies is less characterized

• Regulatory mechanisms: How PIP5KL1 itself is regulated (transcriptionally and post-translationally)

• Evolutionary conservation: Functional differences across species despite sequence homology

How might emerging technologies enhance PIP5KL1 antibody applications?

Future research will benefit from:

• High-resolution imaging techniques: Super-resolution microscopy to visualize PIP5KL1 at membrane microdomains

• Single-cell proteomics: Detecting PIP5KL1 expression heterogeneity across cell populations

• Improved proximity labeling: More sensitive detection of PIP5KL1 interaction partners

• Phosphoproteomics integration: Correlating PIP5KL1 status with broader signaling networks

• Cryo-EM structural analysis: Understanding PIP5KL1's scaffolding structure when bound to partners